Addison Advisors’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.3K | Buy |
111
+24
| +28% | +$5.25K | 0.01% | 511 |
|
|
2025
Q1 | $19.5K | Sell |
87
-9
| -9% | -$2.02K | 0.01% | 507 |
|
|
2024
Q4 | $31.4K | Buy |
96
+8
| +9% | +$2.62K | 0.01% | 444 |
|
|
2024
Q3 | $26.4K | Sell |
88
-5
| -5% | -$1.5K | 0.01% | 472 |
|
|
2024
Q2 | $30.6K | Buy |
93
+4
| +4% | +$1.32K | 0.01% | 427 |
|
|
2024
Q1 | $35.2K | Sell |
89
-94
| -51% | -$37.2K | 0.01% | 399 |
|
|
2023
Q4 | $64.4K | Buy |
183
+41
| +29% | +$14.4K | 0.03% | 326 |
|
|
2023
Q3 | $53.3K | Buy |
142
+39
| +38% | +$14.6K | 0.02% | 315 |
|
|
2023
Q2 | $39.4K | Buy |
103
+12
| +13% | +$4.59K | 0.02% | 347 |
|
|
2023
Q1 | $31.5K | Buy |
91
+8
| +10% | +$2.77K | 0.02% | 350 |
|
|
2022
Q4 | $19.5K | Buy |
83
+41
| +98% | +$9.65K | 0.01% | 380 |
|
|
2022
Q3 | $10K | Sell |
42
-1
| -2% | -$238 | 0.01% | 452 |
|
|
2022
Q2 | $13K | Sell |
43
-31
| -42% | -$9.37K | 0.01% | 416 |
|
|
2022
Q1 | $30K | Buy |
74
+51
| +222% | +$20.7K | 0.02% | 352 |
|
|
2021
Q4 | $11K | Buy |
23
+19
| +475% | +$9.09K | 0.01% | 399 |
|
|
2021
Q3 | $2K | Buy |
+4
| New | +$2K | ﹤0.01% | 391 |
|